Brain Behavior & Immunity - HealthNeurosciencePeer-reviewed journal article
FINCA disease mouse model exhibits altered behaviour and immune response
Anniina E. HiltuneniD, Salla M. KangasiD, Aishwarya GondaneiD, Henna Koivisto, Kari SalokasiD, Anne HeikkineniD, Antti M. SaloiD, Tapio RöningiD, Antti Tallgren, Virpi GlumoffiD, Maria C. DenisiD, Niki KaragianniiD, Johanna MyllyharjuiD, Markku T VarjosaloiD, Heikki TanilaiD, Harri M. ItkoneniD, Mika RämetiD, Johanna UusimaaiD, Reetta HinttalaiD
Abstract
Fibrosis, neurodegeneration and cerebral angiomatosis (FINCA) is a childhood-onset multi-organ neurodevelopmental disorder associated with multi-organ manifestations and recurrent infections. The disease is caused by variants in NHLRC2 initiating a cascade of unknown pathological events. Previously, we have demonstrated that despite the significant decrease at the molecular level, the compound heterozygosity of knock out and p.Asp148Tyr alleles in NHLRC2 does not lead to a severe phenotype in mice. Here, we analysed the behavioural and immunological phenotype of the FINCA mice and studied the molecular pathways affected by p.Asp148Tyr in NHLRC2 using mouse and human-derived cell culture models. The FINCA mice displayed a mild hyperactivity and deficient early immune response when challenged with LPS leading to altered cytokine responses, including IFN{gamma}, IL-12, and TNF. By comparing gene expression and putative interaction partners affected by p.Asp148Tyr, we identified Rho GTPase signalling as the common pathway. Altogether, these results establish a multi-dimensional impact of the p.Asp148Tyr variant in NHLRC2. Knowledge of the molecular pathways affected by NHLRC2 and the natural course of FINCA disease progression are instrumental for the development of effective therapeutics. Summary statementFINCA is a paediatric neurodevelopmental and multi-organ disorder caused by variants in NHLRC2. Here, mild hyperactivity in connection with altered early immune response is described in the FINCA mouse model.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: statistical model
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 11th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The role of the NLRP3 inflammasome in a CLN2 mouse model of neuroinflammation
Kathryn Sanchez, Samantha Elizalde, … Miriam S. Domowicz·bioRxiv·Oct 14, 2026
- A PATHOGENIC NFKB2 VARIANT CAUSES COMBINED IMMUNODEFICIENCY WITH THYMIC AND PERIPHERAL LYMPHOID DEFECTS IN RATS
Séverine Remy, Laurent Tesson, … Ignacio Anegón·bioRxiv·Oct 8, 2026
- MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge: implications for Rett Syndrome.
María Inés Zalosnik, María Carolina Fabio, … Alicia L. Degano·Scientific ReportsPeer-reviewed·May 26, 2021
- A murine model of hnRNPH2-related neurodevelopmental disorder recapitulates clinical features of human disease and reveals a mechanism for genetic compensation of HNRNPH2
Ané Korff, Xiaojing Yang, … Hong Joo Kim·bioRxiv·Mar 17, 2022
- Wild type bone marrow-derived microglia-like cells mitigate strain-dependent neuropathology in Csf1r mutant mice.
Isis Taylor, Omkar L. Patkar, … David Arthur Hume·bioRxiv·Jan 16, 2025
- Cortical interneuron loss and seizure generation as novel clinically relevant disease phenotypes in Cln2R207X mice
Keigo Takahashi, Elizabeth M. Eultgen, … Jonathan D. Cooper·bioRxiv·Mar 11, 2022